id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-309886-j63cpzj2	Pacha, Omar	COVID-19: a case for inhibiting IL-17?	2020-05-01		.txt	text/plain	1565	78	42	For MERS-CoV, SARS-CoV and SARS-CoV-2, the severity of disease was shown to positively correlate with levels of IL-17 and other T helper 17 (T H 17) cell-related pro-inflammatory cytokines, such as IL-1, IL-6, IL-15, TNF and IFNγ 1,6 . Here, we argue that targeting IL-17 is immunologically plausible as a strategy to prevent acute respiratory distress syndrome (ARDS) in coronavirus disease 2019 (COVID-19) and discuss why we think that a clinical trial of a drug in this class could be a logical addition to the effort to find effective therapies. Here, we argue that targeting IL-17 is immunologically plausible as a strategy to prevent acute respiratory distress syndrome (ARDS) in coronavirus disease 2019 (COVID-19) and discuss why we think that a clinical trial of a drug in this class could be a logical addition to the effort to find effective therapies.	./cache/cord-309886-j63cpzj2.txt	./txt/cord-309886-j63cpzj2.txt